Five-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloon
January 25, 2021
Two major randomized controlled trials (RCTs) show no difference in mortality between patients trea
Day: January 25, 2021
Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and Innovation
Samsung Bioepis New Headquarters
Samsung Bioepis
- Located in Korea’s ‘Bio Cluster’ of Songdo in the Incheon Free Econo
Philips and Spanish healthcare group Vithas sign strategic agreement to incorporate Philips’ most advanced technologies into Vithas hospitals and clinics
January 25, 2021
- 5-year alliance will provide Vithas Group with state-of-the-art diagnostic imaging, image viewing
Philips and Rennes University Hospital sign 5-year technology, research and innovation partnership to advance patient care
January 25, 2021
- Hospital will have access to Philips’ latest technologies and informatics solutions to enhance the d
Philips delivers Q4 sales of EUR 6.0 billion, with 7% comp. sales growth; income from cont. operations increases to EUR 608 million, Adjusted EBITA margin improves 110 bps to 19.0%, and operating cash flow increases to EUR 1,305 million
January 25, 2021
Fourth-quarter highlights
• Sales amounted to EUR 6.0 billion, with 7% comparable sales grow…
FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
SHANGHAI, China, Jan. 25, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation…
Continue Reading